eFFECTOR is developing a new class of small molecule therapeutics that act on protein targets that selectively regulate translational control of gene expression.
eFFECTOR Therapeutics is pioneering the discovery and development of translation regulators as a new class of small molecule therapeutics for cancer and other serious diseases.
eFFECTOR is built on superior chemical and biological expertise. Through the fusion of these two disciplines, protein translation can be pharmaceutically controlled for the first time.
Learn more about eFFECTOR’s platform to identify regulators of translation and develop drugs against new targets for therapeutic intervention.
11180 Roselle Street
San Diego, CA 92121